GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (A4HQI9)

Analyse AlphaFold monomer V2.0 prediction for cap-specific mRNA… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A4HQI9
Type
protein
Length
398 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xD65e9d6E89E7Ebb7c293A3b63fCda2B159ce6e3e
Molecule
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1
UniProt
A4HQI9
Pockets
2 · best druggability 0.69

Structure

1 distinct chain · 46% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1protein39846% helix, 14% strandA4HQI9

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15700.690.7854empty
2860.350.7517empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.